215 related articles for article (PubMed ID: 12124872)
21. Development of a CENP-A/CENP-B-specific immune response in a patient with systemic sclerosis.
Mahler M; Mierau R; Genth E; Blüthner M
Arthritis Rheum; 2002 Jul; 46(7):1866-72. PubMed ID: 12124871
[TBL] [Abstract][Full Text] [Related]
22. Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma.
Gelber AC; Pillemer SR; Baum BJ; Wigley FM; Hummers LK; Morris S; Rosen A; Casciola-Rosen L
Ann Rheum Dis; 2006 Aug; 65(8):1028-32. PubMed ID: 16414973
[TBL] [Abstract][Full Text] [Related]
23. Epitope mapping of human centromere autoantigen centromere protein C (CENP-C); heterogeneity of anti-CENP-C response in rheumatic diseases.
Sugimoto K; Kuriyama K; Himeno M; Muro Y
J Rheumatol; 1998 Mar; 25(3):474-81. PubMed ID: 9517766
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
[TBL] [Abstract][Full Text] [Related]
25. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
[TBL] [Abstract][Full Text] [Related]
26. The centromere kinesin-like protein, CENP-E. An autoantigen in systemic sclerosis.
Rattner JB; Rees J; Arnett FC; Reveille JD; Goldstein R; Fritzler MJ
Arthritis Rheum; 1996 Aug; 39(8):1355-61. PubMed ID: 8702444
[TBL] [Abstract][Full Text] [Related]
27. The immunodominant epitope of centromere-associated protein A displays homology with the transcription factor forkhead box E3 (FOXE3).
Perosa F; Vicenti C; Racanelli V; Leone P; Valentini G; Dammacco F
Clin Immunol; 2010 Oct; 137(1):60-73. PubMed ID: 20630806
[TBL] [Abstract][Full Text] [Related]
28. Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis.
Kim D; Peck A; Santer D; Patole P; Schwartz SM; Molitor JA; Arnett FC; Elkon KB
Arthritis Rheum; 2008 Jul; 58(7):2163-73. PubMed ID: 18576347
[TBL] [Abstract][Full Text] [Related]
29. Anti-endothelial cell antibodies from patients with limited cutaneous systemic sclerosis bind to centromeric protein B (CENP-B).
Servettaz A; Tamby MC; Guilpain P; Reinbolt J; Garcia de la Penã-Lefebvre P; Allanore Y; Kahan A; Meyer O; Guillevin L; Mouthon L
Clin Immunol; 2006 Aug; 120(2):212-9. PubMed ID: 16580263
[TBL] [Abstract][Full Text] [Related]
30. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
31. New centromere autoantigens identified in systemic sclerosis using centromere protein microarrays.
Song G; Hu C; Zhu H; Wang L; Zhang F; Li Y; Wu L
J Rheumatol; 2013 Apr; 40(4):461-8. PubMed ID: 23418382
[TBL] [Abstract][Full Text] [Related]
32. Low prevalence of autoantibodies to CENP-H, -I, -K, -L, -M, -N, -T and -U in a Japanese cohort of anti-centromere positive samples.
Saito A; Muro Y; Sugiura K; Akiyama M
Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):57-63. PubMed ID: 23083211
[TBL] [Abstract][Full Text] [Related]
33. Clinical and serological evaluation of a novel CENP-A peptide based ELISA.
Mahler M; Maes L; Blockmans D; Westhovens R; Bossuyt X; Riemekasten G; Schneider S; Hiepe F; Swart A; Gürtler I; Egerer K; Fooke M; Fritzler MJ
Arthritis Res Ther; 2010; 12(3):R99. PubMed ID: 20487535
[TBL] [Abstract][Full Text] [Related]
34. Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis.
Harrison BJ; Silman AJ; Hider SL; Herrick AL
Arthritis Rheum; 2002 Dec; 46(12):3312-6. PubMed ID: 12483737
[TBL] [Abstract][Full Text] [Related]
35. Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies.
Earnshaw W; Bordwell B; Marino C; Rothfield N
J Clin Invest; 1986 Feb; 77(2):426-30. PubMed ID: 3511098
[TBL] [Abstract][Full Text] [Related]
36. Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study.
McHugh NJ; Whyte J; Artlett C; Briggs DC; Stephens CO; Olsen NJ; Gusseva NG; Maddison PJ; Black CM; Welsh K
Clin Exp Immunol; 1994 May; 96(2):267-74. PubMed ID: 8187334
[TBL] [Abstract][Full Text] [Related]
37. An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera.
Kuwana M; Kaburaki J; Medsger TA; Wright TM
Arthritis Rheum; 1999 Jun; 42(6):1179-88. PubMed ID: 10366110
[TBL] [Abstract][Full Text] [Related]
38. Eukaryotic expression of recombinant human centromere autoantigen and its use in a novel ELISA for diagnosis of CREST syndrome.
Stahnke G; Meier E; Scanarini M; Northemann W
J Autoimmun; 1994 Feb; 7(1):107-18. PubMed ID: 8198697
[TBL] [Abstract][Full Text] [Related]
39. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
[TBL] [Abstract][Full Text] [Related]
40. The heterogeneity of anticentromere antibodies in immunoblotting analysis.
Muro Y; Sugimoto K; Okazaki T; Ohashi M
J Rheumatol; 1990 Aug; 17(8):1042-7. PubMed ID: 2213779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
